Thu. 28 Mar 2024, 5:05pm ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Zevra Therapeutics (NASDAQ:ZVRA) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.27) by 48.15 percent. The company reported quarterly sales of $13.217 million which beat the analyst consensus estimate of $11.738 million by 12.60 percent. This is a 474.65 percent increase over sales of $2.300 million the same period last year.